United States securities and exchange commission logo





                            November 1, 2021

       Yulin Wang
       Chief Executive Officer
       Meihua International Medical Technologies Co., Ltd.
       88 Tongda Road, Touqiao Town
       Guangling District, Yangzhou, 225000
       People   s Republic of China

                                                        Re: Meihua
International Medical Technologies Co., Ltd.
                                                            Amendment No. 4 to
                                                            Registration
Statement on Form F-1
                                                            Filed October 21,
2021
                                                            File No. 333-258659

       Dear Mr. Wang:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.

       Amendment No. 4 to Form F-1 filed October 21, 2021

       Index to the Consolidated Financial Statements, page F-1

   1.                                                   Please provide interim
financial statements for the six-months ended June 30, 2021, along
                                                        with the corresponding
prior year period in accordance with Item 4.b. of Form F-1 with
                                                        reference to Item
8.A.5. of Form 20-F.
       Exhibit 23.1, page II-2

   2.                                                   Please request a
revised consent from Briggs & Veselka Co. that references the correct
                                                        amendment number. In
this regard, the consent dated October 21, 2021 is included in the
                                                        fourth amendment to the
Form F-1 rather than the third amendment.
 Yulin Wang
Meihua International Medical Technologies Co., Ltd.
November 1, 2021
Page 2

       You may contact Tracey Houser at 202-551-3736 or Brian Cascio at
202-551-3676 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Jane Park at 202-551-7439 or Celeste Murphy at 202-551-3257 with any
other questions.



                                                         Sincerely,
FirstName LastNameYulin Wang
                                                     Division of Corporation
Finance
Comapany NameMeihua International Medical Technologies Co., Ltd.
                                                     Office of Life Sciences
November 1, 2021 Page 2
cc:       Joe Laxague, Esq.
FirstName LastName